The molecular analysis for therapy choice (NCI-MATCH) trial: lessons for genomic trial design

KT Flaherty, R Gray, A Chen, S Li… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …
被引用次数：174 相关文章

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

KT Flaherty, R Gray, A Chen, S Li… - Journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

KT Flaherty, R Gray, A Chen, S Li, D Patton… - JNCI: Journal of the …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The proportion of tumors of various histologies that may respond to drugs targeted to …
[HTML] nih.gov

[HTML][HTML] The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

KT Flaherty, R Gray, A Chen, S Li, D Patton… - JNCI Journal of the …, 2020 - ncbi.nlm.nih.gov
Background The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …

The molecular analysis for therapy choice (NCI-MATCH) trial: Lessons for genomic trial design

NCIM Team - Journal of the National Cancer Institute, 2020 - pure.johnshopkins.edu
Background: The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …

The molecular analysis for therapy choice (NCI-MATCH) trial: Lessons for genomic trial design

NCIM Team - Journal of the National Cancer Institute, 2020 - mayoclinic.elsevierpure.com
Background: The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …
[PDF] oup.com

[PDF][PDF] The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

KT Flaherty, R Gray, A Chen, S Li… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.

KT Flaherty, R Gray, A Chen, S Li, D Patton… - Journal of the …, 2020 - europepmc.org
Background The proportion of tumors of various histologies that may respond to drugs
targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG …